EE200200240A - Lämmastikoksiidi kasutamine hingamisteede ahenemise raviks - Google Patents

Lämmastikoksiidi kasutamine hingamisteede ahenemise raviks

Info

Publication number
EE200200240A
EE200200240A EEP200200240A EEP200200240A EE200200240A EE 200200240 A EE200200240 A EE 200200240A EE P200200240 A EEP200200240 A EE P200200240A EE P200200240 A EEP200200240 A EE P200200240A EE 200200240 A EE200200240 A EE 200200240A
Authority
EE
Estonia
Prior art keywords
treatment
nitric oxide
airway constriction
constriction
airway
Prior art date
Application number
EEP200200240A
Other languages
English (en)
Estonian (et)
Inventor
Hjoberg Josephine
Hedenstierna G�ran
H�gman Marieann
Original Assignee
Aga Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aga Ab filed Critical Aga Ab
Publication of EE200200240A publication Critical patent/EE200200240A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200200240A 1999-11-03 2000-11-02 Lämmastikoksiidi kasutamine hingamisteede ahenemise raviks EE200200240A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903985A SE9903985D0 (sv) 1999-11-03 1999-11-03 Use of nitric oxide
PCT/SE2000/002153 WO2001032202A1 (en) 1999-11-03 2000-11-02 Use of nitric oxide for the treatment of airway constriction

Publications (1)

Publication Number Publication Date
EE200200240A true EE200200240A (et) 2003-06-16

Family

ID=20417596

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200240A EE200200240A (et) 1999-11-03 2000-11-02 Lämmastikoksiidi kasutamine hingamisteede ahenemise raviks

Country Status (20)

Country Link
EP (1) EP1225913B8 (xx)
JP (1) JP2003513048A (xx)
CN (1) CN1230199C (xx)
AR (1) AR026335A1 (xx)
AT (1) ATE302023T1 (xx)
AU (1) AU778347B2 (xx)
BR (1) BR0015329A (xx)
CA (1) CA2389655A1 (xx)
CZ (1) CZ20021559A3 (xx)
DE (1) DE60022070T2 (xx)
EE (1) EE200200240A (xx)
ES (1) ES2248153T3 (xx)
HU (1) HUP0203065A3 (xx)
IL (1) IL149170A0 (xx)
MX (1) MXPA02004069A (xx)
NO (1) NO20022113D0 (xx)
PL (1) PL354653A1 (xx)
SE (1) SE9903985D0 (xx)
WO (1) WO2001032202A1 (xx)
ZA (1) ZA200203391B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
US6601580B1 (en) * 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
WO2003088961A1 (en) 2002-04-19 2003-10-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
WO2004000368A1 (en) * 2002-06-21 2003-12-31 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
CA2745411A1 (en) * 2008-12-03 2010-06-10 Ltt Bio-Pharma Co., Ltd. Inhalant containing modified superoxide dismutase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE560928T1 (de) * 1990-12-05 1994-09-22 Gen Hospital Corp Vorrichtung zum behandeln einer lungengefässverengung und von asthma.
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
WO1996039409A1 (en) * 1995-06-05 1996-12-12 Nitromed, Inc. Nitrosylated and nitrated superoxide oxidants and reductants
GB9801398D0 (en) * 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds

Also Published As

Publication number Publication date
HUP0203065A2 (hu) 2003-01-28
AR026335A1 (es) 2003-02-05
HUP0203065A3 (en) 2006-07-28
DE60022070T2 (de) 2006-03-30
DE60022070D1 (de) 2005-09-22
EP1225913B1 (en) 2005-08-17
NO20022113L (no) 2002-05-02
BR0015329A (pt) 2002-07-09
NO20022113D0 (no) 2002-05-02
CN1230199C (zh) 2005-12-07
MXPA02004069A (es) 2003-08-20
AU778347B2 (en) 2004-12-02
JP2003513048A (ja) 2003-04-08
CN1387441A (zh) 2002-12-25
EP1225913A1 (en) 2002-07-31
CZ20021559A3 (cs) 2003-05-14
AU1745601A (en) 2001-05-14
ES2248153T3 (es) 2006-03-16
ZA200203391B (en) 2002-12-20
ATE302023T1 (de) 2005-09-15
SE9903985D0 (sv) 1999-11-03
IL149170A0 (en) 2002-11-10
CA2389655A1 (en) 2001-05-10
PL354653A1 (en) 2004-02-09
WO2001032202A1 (en) 2001-05-10
EP1225913B8 (en) 2005-10-19

Similar Documents

Publication Publication Date Title
HK1097437A1 (en) Therapeutic use of nitric oxide precursor
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
IL196301A0 (en) Medicament for the treatment of hapatitis c
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
GB0221064D0 (en) Wound dressings for the treatment of wound infection
EE200300226A (et) Lämmastikoksiidi inhaleerimine
HUP0202150A3 (en) Use of nitric oxide donors for inducing neurogenesis
EP1207811A4 (en) STAIN OXIDE RELEASE MEDICAL ARTICLES
HK1069385A1 (en) Heterocyclic compound and medicinal use thereof
GB0004531D0 (en) The treatment of respiratory diseases
IL156139A0 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
EE200200240A (et) Lämmastikoksiidi kasutamine hingamisteede ahenemise raviks
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
IL144115A0 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
HK1070561A1 (en) Use of specific dose of fandaparinux sodium for the treatment of acs
GB0312566D0 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20012540D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20022244L (no) Behandling av SLE med dehydroepiandrosteron
NO20013464D0 (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
AU2908501A (en) Combination therapy for the treatment of inflammatory and respiratory diseases
AU2728301A (en) Combination therapy for the treatment of inflammatory and respiratory diseases
GB0112084D0 (en) The treatment of respiratory infections